Header

Skip to main content

Rockville Companies Make Significant Impact During COVID-19

Updated June 12, 2020

During our public health crisis and time of uncertainty, several Rockville businesses–along with businesses in the surrounding areas–are making significant contributions during the COVID-19 pandemic. Company impacts vary, but some of the ways they are influencing change and supporting the greater good include:

  • Developing and manufacturing new products that align with their current core business strengths;
  • Pivoting company operations to meet new community needs;
  • Creating resources and tools to help small businesses remain operational during shelter-in-place mandates; and
  • Using company resources and influence to support frontline workers during the public health crisis.

If your Rockville business is contributing to the stabilization of the COVID-19 health crisis, we’d love to feature it here. Contact us at admin@rockvilleredi.org with the details.

Maryland’s Life Sciences Companies Collaborate on COVID-19 Vaccines, Therapeutics, and Diagnostics
Maryland’s life sciences companies are working together to create vaccines, therapeutics, and diagnostics. Here is a list of Rockville companies and their current COVID-19 initiatives as provided by Maryland Life Sciences, a division of Maryland Tech Council:

  • 20/20 Gene Systems, based in Rockville, is importing a CE-marked rapid diagnostic for emergency use in the U.S.
  • NEW! It was recently announced that Emergent BioSolutions has expanded a contract with the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Department of Health and Human Services, to expand production capabilities and manufacturing support for COVID-19 vaccine candidates through 2021. This will bring approximately $85.5 million into its Rockville manufacturing location as well as two, Baltimore-area sites.
  • GenArraytion, based in Rockville, is providing a validated COVID-19 RNA sequence assay.
  • GlaxoSmithKline, which has an R&D center for vaccines in Rockville, has offered to share its vaccine adjuvant with others developing vaccines.
  • Immunomic Therapeutics, Inc. in Rockville is working to build a COVID-19 vaccine, evaluate it, and seek grant funding to pay for the clinical study.
  • Integrated Biotherapeutics, based in Rockville, is working on vaccines and therapeutics.
  • Navitas Life Sciences, located in Rockville, is offering clinical research resources.
  • Next Molecular Analytics, which has operations in Rockville and Chester, Virginia, is providing RNA sequencing for COVID-19.
  • Sanaria & Protein Potential, both based in Rockville, are working on diagnostics and vaccines.
  • Sequella, based in Rockville, has resources for drug manufacturing.

Other Maryland life sciences companies contributing to COVID-19 initiatives include:

  • Adaptive Phage Therapeutics in Gaithersburg is in talks with a partner to help with rapid production of a COVID-19 vaccine candidate for a planned clinical study.
  • UPDATED! Altimmune, based in Gaithersburg, is developing an intranasal vaccine. Recently, the biotech company received a regulatory nod to move forward with clinical trials for a COVID-19 treatment, which may help prevent severe lung inflammation from the disease and reduce hospitalizations. The therapeutic is a separate candidate from Altimmune’s COVID-19 vaccine candidate, which was announced earlier this year.
  • Asell, based in Owings Mills, is providing expertise with diagnostic development to the U.S. Biomedical Advanced Research and Development Authority.
  • Children’s National Hospital, based in D.C., is offering clinical research collaborations to regional biotech companies developing COVID-19 solutions.
  • Emergent Biosolutions is providing services in Gaithersburg and Baltimore to Novavax and SF-based Vaxart.
  • Novavax, based in Gaithersburg, is developing a vaccine and partnered with Emergent Biosolutions for contract manufacturing and development.
  • Pfizer, which is the parent company of Columbia-based Meridian Medical Technologies, is offering to share its resources and tools.
  • Pharmaceutics International, based in Hunt Valley, is offering to provide access to a sterile fill and finish operation.
  • Qiagen Labs, which has an operation in Germantown, is ramping up manufacturing of sample processing kits for COVID-19, and adding the new coronavirus to its infectious disease test panel.
  • Zalgen Labs, based in Germantown, is developing a diagnostic.

Rockville Distiller & Organic Beauty Company Respond to Hand Sanitizer Need
In mid-March as the COVID-19 pandemic was rapidly spreading and hand sanitizer was scarce, Twin Valley Distillers, which normally produces spirits such as rum, vodka, whisky and bourbon, pivoted its business to respond to a vital community need—hand sanitizer.

With traditional sanitizer companies unable to keep up with the public demand, owner Eduardo Zuniga began production in his facility. In addition to offering a solution to a public health issue, it also kept his employees working full-time when a reduction of hours was imminent. Twin Valley Distillers helped supply hand sanitizer to local first responders in Montgomery County, the city of Baltimore, and the city of Frederick.

Aisha Khadar of Sha’s Creations, a maker of organic body products and one of the featured women-owned retailers in Maryland Women’s Business Center’s business incubator–Shop Local Rockville–received a grant from Montgomery County’s from newly created Local Production Fund. She is using her grant to manufacture hand sanitizer and liquid disinfecting soaps for our community.

Rockville Ping Pong Company Makes Masks for Healthcare Workers
Rockville resident Richard Lee owns Joola Table Tennis, a company that makes ping pong tables and has its North American headquarters based in Rockville. He’s pivoted his company to produce face masks primarily for healthcare workers. Lee selected to make face masks because his sister is a frontline healthcare worker and because they not only protect the people wearing them, but also the people around them. So far, the company has produced more than 500,000 face masks and will continue to make masks to keep communities safe during COVID-19.

Rockville’s True Respite Brewing Company Helps Breweries Across the Country Remain Operational
To help craft breweries reach customers and maintain sales during the pandemic, True Respite Brewing Company developed a novel online platform—Biermi.

Through the website, customers can select a local brewery, place an online order, and schedule a pick-up or delivery (where available). So far, nearly 90 breweries in 27 states have gone live on the Biermi platform, with more on the way every day!

This groundbreaking platform has helped breweries remain operational during this critical time, facilitating more than $500k in sales to date. And of course, True Respite offers curbside pick-up and delivery service for local Marylanders as well.

Dawson’s Market & Local Restaurants Provide Meals for Frontline Workers
Efforts in Montgomery County to provide food to frontline workers—doctors, nurses, caregivers & support staff, EMTs, firefighters and the countless others who are fighting the pandemic—now includes a specific campaign for Adventist HealthCare Shady Grove Medical Center and its affiliates. Julie Sapper spearheads this campaign and the community is grateful for her devotion and commitment.

Several Rockville businesses/restaurants have participated including Dawson’s Market whose patrons recently purchased 284 meals delivered to frontline workers, The Bean Bag Deli & CateringBotanero Restaurant (which is also accepting online donations to provide meals for the Rockville Fire Department), Fontina Grille, and il Pizzico. The next participating restaurant is Berries & Bowls (The Kentlands in Gaithersburg), which is trying to provide 500 bowls to the dedicated frontline workers in all departments of the hospital(s). Donate here or visit the campaign’s Facebook Page to support local restaurants/efforts.

Sources:
https://technical.ly/baltimore/2020/03/20/17-maryland-biotech-companies-collaborating-vaccines-therapeutics-diagnostics-covid19-coronavirus/
https://biobuzz.io/covid-19-vaccine-progress-from-8-biohealth-capital-region-companies/
https://biobuzz.io/covid-19-vaccine-progress-from-8-biohealth-capital-region-companies/
https://www.baltimoresun.com/coronavirus/bs-md-covid19-blood-tests-20200412-wcl6fallvfei3h5dgvczu6fmti-story.html
https://bethesdamagazine.com/bethesda-beat/coronavirus/rockville-distillery-switches-to-producing-hand-sanitizer/
https://bethesdamagazine.com/bethesda-beat/coronavirus/rockville-distillery-switches-to-producing-hand-sanitizer/
https://open.maryland.gov/blog/maryland-brewery-launches-online-platform-beer-delivery/
https://dawsonsmarket.com/
https://www.berriesandbowls.com/
https://www.nbcwashington.com/news/local/rockville-mans-ping-pongcompany-making-masks-for-health-care-workers/2271557/
 

Senator Van Hollen Releases Fact Sheets to Help Marylanders During COVID-19

Keeping Marylanders Informed during the COVID-19 public health crisis. 

Senator Van Hollen’s office recently posted detailed fact sheets and resources for Maryland residents related to the three Federal stimulus packages.

Download the Phase 1 & 2 Fact Sheet Here for information about benefits for Marylanders.

Download the Phase 3 Fact Sheet Here for information about federal funding available through the CARES Act.

Download the Phase 3.5 Fact Sheet Here for information about additional funding for small- and medium-sized businesses and nonprofits. 

If you’d like more information, visit Senator Van Hollen’s online Coronavirus Resource Center. Or, visit REDI’s resource page here.

Montgomery County Council Approves $20m in COVID-19 Aid Funding

Updated April 9, 2020

Requirements for the County’s Public Health Emergency Grant Fund (PHEG) are online now. The application should go live early next week. Here is some of the information that you should gather in anticipation of the opening of the online application.

Business Eligibility:

  1. Must be a “Business in Good Standing” (see below).
  2. Employ 100 or fewer full-time-equivalent employees.
  3. Physically located in the County (see specific requirement).
  4. Incurred financial losses caused directly or indirectly by the Covid-19 public health emergency.
  5. Must apply for any applicable State and Federal programs to qualify for County assistance.

Documentation Needed:

6. Supply at least two of these documents:

  • Tax Return 2019 (or 990) if available.
  • Tax Return 2018 (or 990).
  • Tax Return 2017 (or 990).
  • Interim Financial Statements and any Tax Return the business filed with the IRS (if your business is less than 2 years old).
  • 2019 Profit and Loss Statement (if your business is less than 2 years old).
  • Schedule C from your Personal Tax Returns (for Sole Proprietors) 2018.
  • Schedule C from your Personal Tax Returns (for Sole Proprietors) 2017.

7. Supply these documents which are required to demonstrate financial loss due to the health emergency:

  • Interim Monthly or Quarterly Financials for Calendar Year 2020, OR
  • Monthly or Quarterly Sales Tax Filings for Calendar Year 2020, OR
  • 2020 Bank Statements for businesses with fewer than 5 employees.
  • Evidence of application to Federal and/or State COVID-19 assistance programs, including award or denial letters. You must apply for any applicable State and Federal programs to qualify for County assistance.
  • Articles of Incorporation or Articles of Organization.
  • Invoice or Quote for Telework equipment or software for your employees, if requesting funds for this purpose.

“Good Standing”:
8. Is your business registered and in “Good Standing” with the State of Maryland?

  • Search for your business entity at Maryland Business Express/Business Entity Search.
  • Enter your business name and select “Search”.
  • Your business will be listed if you are registered.
  • Select your business and check under the General Information tab to verify that your business is in “Good Standing.”

Special thanks to the Gaithersburg/Germantown Chamber of Commerce for the information synopsis. 

ORIGINAL POST: April 2, 2020

Public Health Emergency Grant Program will provide emergency grant funding to small businesses and nonprofits

On Tuesday, March 31, 2020, the Montgomery County Council approved $20 million in emergency funding to provide grants to small businesses and nonprofits that have been impacted by COVID-19. At least 25% of the funds are required to go to restaurants and retail storefronts; that figure can be higher.

The Council also approved an additional $6 million in funding with $5 million going for direct financial assistance to Montgomery County residents and $1 million allocated to support safety net services through the Department of Health and Human Services.

The Council approved the COVID-19 Economic Relief Act (Expedited Bill 16-20, Economic Development Fund – Public Health Emergency Grant Program – Established) and the accompanying special appropriations on an emergency basis and authorized the County Executive to begin providing this assistance as quickly as possible.

The measures include the following:

  • Public Health Emergency Grant Program: This new program provides grant funding up to $75,000 per business or nonprofit for county businesses or nonprofits with 100 or fewer full-time-equivalent employees that can demonstrate financial losses caused by the public health emergency. Grant funding must be used for employee wages and benefits, taxes, debt, rent or other operating losses during the public health emergency.
  • Microgrants: The grant program includes microgrant funding for local businesses and nonprofits up to $2,500 to cover the costs associated with purchasing teleworking equipment and technology and supporting teleworking capabilities during the Covid-19 emergency.
  • Special appropriation for the Public Health Emergency Grant Program: The Council funded a $20 million special appropriation for the Fiscal Year 2020 Operating Budget to finance the Public Health Emergency Grant Program through the County’s Economic Development Fund. The source of the funds is the County’s General Fund Reserves. The impact of the special appropriation will be offset by the County Executive’s recommended reduction of FY20 expenditures from the Retiree Health Benefits Trust Non-Department Account based on the new actuarial evaluation lowering the required contribution.
  • Special appropriation to the COVID-19 Human Services and Community assistance Non-Departmental Account: The Council also funded a $6 million special appropriation with $5 million for financial assistance to residents and $1 million to support safety net programs provided by the Department of Health and Human Services and its non-profit partners to assist vulnerable populations.

Application Information Coming Soon

The County is now developing the application process for accessing those funds, which will be shared when it becomes available. Here are some key items to know:

  • Businesses and nonprofits with up to 100 employees can apply for a maximum grant of $75,000.
  • Funds may be used to cover employee wages and benefits, taxes, debt, rent, and other operating expenses.
  • The principal place of business must be in the county.
  • Sole proprietorships are eligible.
  • Includes mini-grants of up to $2,500 to cover technology equipment and software purchases for remote work.

Whiteford Welcomes Litigation and Maritime Attorneys

Whiteford Taylor & Preston, a law firm with multiple locations in Maryland, including Rockville, announces that Charles L. Simmons, Jr., and James R. Jeffcoat have joined the firm in Baltimore.

“We are delighted to welcome Charlie and James,” said Managing Partner Martin Fletcher.  “Together, they are a formidable addition to an already deep litigation bench.  Each also brings significant experience in the field of maritime law, growing our capabilities in that sector measurably.”

With nearly 25 years of experience as a litigator and trial lawyer, Mr. Simmons’ practice extends across business, commercial and insurance defense litigation, as well as insurance coverage, intellectual property, and maritime and construction law. He has significant experience in maritime law, including maritime insurance matters, and teaches maritime law at the University of Baltimore. He also has substantial in-court trial experience representing individuals who have suffered serious injury.

Mr. Jeffcoat is experienced in civil litigation in federal and state courts, including commercial litigation, insurance coverage and defense, admiralty and maritime disputes, and intellectual property litigation. He also has experience with patent infringement actions, including before the International Trade Commission. His practice includes in-court trial experience representing individuals who have suffered serious injury.

Said Mr. Simmons, “We’re excited to join Whiteford.  It’s a compelling, full service platform for serving our clients and, at the same time, expanding our practices.”

About Whiteford, Taylor & Preston LLP
With over 175 attorneys, 
Whiteford, Taylor & Preston provides a comprehensive range of sophisticated, cost-effective business law and litigation services to clients ranging from innovative start-ups to middle market companies to global enterprises.  Our growing Mid-Atlantic footprint includes sixteen offices in Delaware, D.C., Kentucky, Maryland, Michigan, New York, Pennsylvania and Virginia.

MEMA Seeking BioHealth Supplies for Maryland

The Maryland Department of Commerce is working closely with the Maryland Emergency Management Agency (MEMA) to organize emergency suppliers of equipment and services that may aid in the response to the COVID-19 crisis. To be added to a list, please take the following actions:

FIRST, SEND AN EMAIL.

If you are a U.S.-based company, send an email to resource.mema@maryland.gov. Please include company name and address and point-of-contact (email and phone number).

If you are an international-based company, please reach out to the Commerce International Trade and Investment Team member who represents your region. Please provide company name and address and point-of-contact (email and phone number).

THEN, COMPLETE THE RFI.

Please complete the RFI online.

Please consider the following information before completing the steps above.

  1. We do not provide resource request lists but do accept summaries from companies offering goods and services. Please compile a detailed list and an appropriate command staff member will vet your company’s credentials.
  2. All suppliers must be vetted before being entered into the Emergency Supplier Database so please discourage middlemen and consultants from contacting MEMA, and instead, have them pass this information to the supplier.

For any further questions, please contact Ernesto Chanona (ernesto.chanona@maryland.gov) with the Office of BioHealth and Life Sciences.

Alcohol Licensing & Permit Updates from MoCo’s Alcohol Beverage Services

The Licensure, Regulation & Education department of Montgomery County’s Alcohol Beverage Services (ABS) recently released updates regarding alcohol licensing and permits.

Lobby Closed Until Further Notice
Effective March 19, the Visitors Entrance/LRE lobby will be closed to the public.
Call 240-777-1999 for assistance.

License Renewal Extensions
In accordance with the Governor’s order that license periods will be extended for 30 days beyond the declared state of emergency, the deadline to submit an alcoholic beverages license renewal application and the deadline to pick up the renewed license will be extended. Licensees will be informed once new deadlines have been established.

For those wishing to submit the renewal application now, paper applications with a check can be mailed to LRE, 201 Edison Park Drive, Gaithersburg, MD 20878. Applications can also be submitted through the online portal. Use your existing iStore account or create a new account.

Carryout/Delivery Permission for RESTAURANTS
The Board of License Commissioners approved the following resolution authorizing restaurants to sell beer and wine for carryout or delivery with a meal:  While the Governor’s order to close all restaurants as a part of the catastrophic health emergency remains in effect, all restaurants licensed by the Montgomery County Board of License Commissioners may sell sealed containers of beer and wine for off-premises consumption along with a takeout or delivered meal. This permission includes the sale of bottles, cans, growlers, and crowlers for off-premises consumption and does not include the sale of alcoholic drinks in a to-go cup. This permission does not include liquor. This permission expires when the emergency order to close restaurants is lifted. Businesses may deliver beer and wine to Montgomery County addresses along with a meal using their own staff. State law prohibits the delivery of alcohol by a third party, such as Grubhub or Uber Eats. Businesses must apply for this permission through an online form, and permission will be granted administratively by Alcohol Beverage Services staff.

Apply for the permission at:  https://myabs.formstack.com/forms/restaurant_offpremise_permission.

Delivery Permit for BEER and WINE STORES
The Board of License Commissioners has authorized expedited approval of applications for a Retail Delivery permit by for Class BBWHR, ABW, BDBWL, and DBW licenses.

Apply for the permit at www.montgomerycountymd.gov/ABS/Resources/Files/licensure/abs-retail-delivery-application.pdf.

Get the regulations at www.montgomerycountymd.gov/ABS/Resources/Files/licensure/abs-off-premise-delivery-written-ceftification.pdf.

For Orders and Deliveries
ABS has cancelled all open sales orders and open purchase orders for on-premise only accounts due to Governor Hogan’s executive order to close all restaurants and bars (with the exception of carry-out, drive-thru and delivery service). With the new permissions for a delivery permit for on-premise licensees, any items that your account would like will need to be re-ordered through:

Please keep in mind that ABS has implemented a minimum delivery of five cases of wine/spirit and seven cases of beer during this pandemic.

Aurinia Pharmaceuticals Establishes U.S. Commercial Operations in Rockville

Victoria, British Columbia – March 17, 2020: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia”or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the Company has established U.S. commercial center of operations in Rockville, Maryland. The new site will support Aurinia’s plans for growth as it prepares for the potential approval and launch of voclosporin for lupus nephritis in 2021.

Aurinia’s Rockville site at 77 Upper Rock Circle will initially occupy 30,000 square feet, with potential expansions to 120,000 square feet. The company plans to hire up to 100 employees in the first year and up to 500 employees as the company expands its operations. It is located within the I-270 life sciences and biotech corridor, which is widely recognized as a hotbed of leading innovation and industry talent.

The Maryland Department of Commerce has approved a $2 million conditional loan through Advantage Maryland, formerly the Maryland Economic Development Assistance Authority and Fund (MEDAAF), which will be distributed in $1 million increments as each phase of the project is complete. Additionally, Montgomery County has approved a conditional grant of $350,000 per phase of the project, with the City of Rockville contributing $25,000 for each phase. The company is also eligible for Maryland’s Job Creation Tax Credit.

About Aurinia
Aurinia Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by diseases with a high unmet medical need. The Company is currently developing an investigational drug for the treatment of lupus nephritis, focal segmental glomerulosclerosis and dry eye syndrome. The Company’s head office is in Victoria, British Columbia, and focuses its development efforts globally. For further information, see our website at 
www.auriniapharma.com.

Maryland’s Business Express Launches COVID-19 Portal

Rockville Economic Development, Inc. (REDI) is committed to supporting economic growth of The City of Rockville, especially during this uncertain time when businesses are planning and responding to COVID-19.

The State of Maryland has created a portal on its website for businesses impacted by COVID-19, which offers information and additional resources to help businesses navigate this unprecedented event.

This online coronavirus portal also includes a list of FAQs that many businesses will find helpful. Answers to questions include information about:

  • business tax questions,
  • guidelines for employers,
  • fair labor standards,
  • insurance claims,
  • opportunities for financial assistance,
  • statewide closures, and more.

If business owners have specific questions not answered by the FAQs, please email them to Secretary.Commerce@maryland.gov.

Last week, the Small Business Administration released information about disaster assistance in response to the coronavirus, including the possibility of Economic Injury Disaster Loans. We are awaiting information that the State has taken action so we can encourage affected businesses to apply for relief if it becomes available. Click here to download the PDF.

Maryland’s state agencies are working collaboratively to quickly answer questions and help businesses remain operational and minimize economic impact, while safeguarding Maryland residents from COVID-19.

REDI will continue to share information and updates as they relate to our business community.

CDC Releases Interim COVID-19 Guidance for Businesses and Employers

CDC Logo

The CDC has released Interim COVID-19 Guidance for Businesses and Employers to help them plan, prepare and respond to Coronavirus Disease 2019. 

Click here to read these guidelines 
that may help prevent workplace exposures to acute respiratory illnesses, including COVID-19, in non-healthcare settings.

For additional COVID-19 Resources, click here

Altimmune Completes First Development Milestone Toward A Single-Dose Intranasal COVID-19 Vaccine

José Ochoa is the Chief Business Officer of Altimmune and also serves on REDI’s Board of Directors. We commend Altimmune for its swift efforts to develop COVID-19 vaccine technology to help protect public health & safety.

GAITHERSBURG, Md., Feb. 28, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology to protect against COVID-19, the disease caused by the SARS-CoV-2 virus. Altimmune has completed the design and synthesis of the vaccine and is now advancing it toward animal testing and manufacturing.

“With the spread of COVID-19 outside of China, including the first case of unknown origin in the United States, we have taken action to develop and make our vaccine technology available to help address this crisis,” said Vipin K. Garg, Ph.D., President and Chief Executive Officer of Altimmune. “We believe that our intranasal vaccine technology is especially well suited to provide systemic protection against respiratory infections that affect the upper and lower airways and can therefore be a useful tool in preventing further spread of COVID-19. As such, we are actively engaged in discussions with a number of potential partners.”

The new intranasal vaccine is based on the same platform vaccine technology as NasoVAX, the company’s influenza vaccine candidate. Like NasoVAX, the COVID-19 vaccine is designed to provide systemic immunity following a single intranasal dose. A recent Phase 2 clinical study with NasoVAX highlighted the ability of intranasal vaccine delivery to stimulate a durable and broad immune response against the influenza virus.

Altimmune believes the clinical profile of NasoVAX is particularly relevant to COVID-19 because intranasal delivery directs the immune response where it is needed most to protect against respiratory infection, including the likely site of initial viral attack. Clinical testing of the vaccine could begin as early as August.

UPDATE:  March 30, 2020–Altimmune and The University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine.

About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease, immune modulating therapies and vaccines. Our diverse pipeline includes next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™), conjugated immunostimulants for the treatment of cancer (ALT-702) and intranasal vaccines (NasoVAX™, NasoShield™ and AdCOVID™). For more information on Altimmune, please visit www.altimmune.com.